更昔洛韦治疗贝尔麻痹的临床观察  

Observation of the therapeutic effect of Ganciclovi on Bell's palsy

作　　者：杨运周[1] 胡文霞[1] 翟宏江[1] 高长根[1] 

机构地区：[1]安徽省六安市人民医院,237005

出　　处：《中国医学创新》2009年第32期24-25,共2页Medical Innovation of China

摘　　要：目的评价更昔洛韦治疗贝尔(Bell)麻痹的疗效。方法选择贝尔麻痹患者63例,随机分为两组,常规治疗组32例和更昔洛韦组31例。常规治疗组予以激素、维生素治疗;更昔洛韦组在常规治疗的基础上加用更昔洛韦。结果治疗2周后,更昔洛韦组总有效率为94%,常规治疗组为77%,两组比较有显著性差异(P<0.05)。结论更昔洛韦是治疗贝尔麻痹的有效药物,而且未发现明显的不良反应。Objective To evaluate the therapeutic effect of Ganciclovi on Bell＇s palsy. Methods 63 cases of Bell＇s palsy were randomly divided into two groups： routine treatment group（ n = 31 ） and Ganciclovi treatment group（ n = 32 ）. Routine treatment group was given hormone, vitamin. While the Ganciclovi treatment group was given Ganciclovi in addition to routine treatment. Results After two - week - treatment, the overall effective rate was 94% in Ganciclovi treatment group and 77% in routine group, with asignificant difference （P 〈 0. 05 ）. Conclusion Ganciclovi is an effective drug in treating Bell＇s palsy, and it is no obvious side effect.

关 键 词：贝尔麻痹 更昔洛韦 强的松 

分 类 号：R745.12[医药卫生—神经病学与精神病学]